Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy
Krzysztof Kaczmarek(Medical University of Lodz), Marek Grygier(Poznan University of Medical Sciences), Agata Markiewicz(Medical University of Lodz), Rafał Płaksej, Anna Babicz-Sadowska, Paweł Ptaszyński(Medical University of Lodz), Zbigniew Kalarus, Piotr Jakubowski(Medical University of Lodz), Iwona Cygankiewicz(Medical University of Lodz), Jerzy Krzysztof Wranicz(Medical University of Lodz), Witold Streb
Cited by 10
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
|EP Europace|2019|323
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology
|Circulation Arrhythmia and Electrophysiology|2019|286